Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_assertion type Assertion NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_head.
- NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_assertion description "[Subgroup analysis showed the GSTT1 null genotype to be a risk factor for non-Hodgkin lymphoma (NHL) (OR 2.75, 95% CI 1.17, 6.45; p = 0.02; random-effects model) but not for Hodgkin lymphoma (HL), and the effect remained evident in females (OR 1.43, 95% CI 1.04, 1.97; p = 0.03; I(2) = 41.0%, p for heterogeneity = 0.15; fixed-effects model).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_provenance.
- NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_assertion evidence source_evidence_literature NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_provenance.
- NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_assertion SIO_000772 22734843 NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_provenance.
- NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_assertion wasDerivedFrom befree-20140225 NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_provenance.
- NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_assertion wasGeneratedBy ECO_0000203 NP860108.RA9p2Hvb_93j2Zhx9TwY8edfNpkNKrQCSOfd4nllKuFfA130_provenance.